Pharmacokinetic studies of nanoparticles as a delivery system for conventional drugs and herb-derived compounds for cancer therapy: a systematic review

References

• Feng -S-S, Zhao L, Zhang Z, et al. Chemotherapeutic engineering: vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168h in vivo. Chem Eng Sci. 2007;62(23):6641–6648. doi:10.1016/j.ces.2007.08.006
   Web of Science ®Google Scholar
• Rafiei P, Haddadi A. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Int J Nanomedicine. 2017;12:935–947. doi:10.2147/IJN.S12188128184163
   PubMed Web of Science ®Google Scholar
• Vardhan H, Mittal P, Adena SKR, Upadhyay M, Mishra B. Development of long-circulating docetaxel loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles: optimization, pharmacokinetic, cytotoxicity and in vivo assessments. Int J Biol Macromol. 2017;103:791–801. doi:10.1016/j.ijbiomac.2017.05.12528536023
   PubMed Web of Science ®Google Scholar
• Zabaleta V, Ponchel G, Salman H, Agueros M, Vauthier C, Irache JM. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study. Eur J Pharm Biopharm. 2012;81(3):514–523. doi:10.1016/j.ejpb.2012.04.00122516136
   PubMed Web of Science ®Google Scholar
• Qiao H, Li J, Wang Y, Ping Q, Wang G, Gu X. Synthesis and characterization of multi-functional linear-dendritic block copolymer for intracellular delivery of antitumor drugs. Int J Pharm. 2013;452(1–2):363–373. doi:10.1016/j.ijpharm.2013.05.00323680725
   PubMedGoogle Scholar
• Saremi S, Dinarvand R, Kebriaeezadeh A, Ostad SN, Atyabi F. Enhanced oral delivery of docetaxel using thiolated chitosan nanoparticles: preparation, in vitro and in vivo studies. Biomed Res Int. 2013;2013:150478. doi:10.1155/2013/15047823971023
   PubMed Web of Science ®Google Scholar
• Lee JY, Kim JS, Cho HJ, Kim DD. Poly(styrene)-b-poly(DL-lactide) copolymer-based nanoparticles for anticancer drug delivery. Int J Nanomedicine. 2014;9:2803–2813. doi:10.2147/IJN.S6280624940058
   PubMed Web of Science ®Google Scholar
• Bernabeu E, Helguera G, Legaspi MJ, et al. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane(R). Colloids Surf B Biointerfaces. 2014;113:43–50. doi:10.1016/j.colsurfb.2013.07.03624060929
   PubMed Web of Science ®Google Scholar
• Ernsting MJ, Tang WL, MacCallum NW, Li SD. Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models. Biomaterials. 2012;33(5):1445–1454. doi:10.1016/j.biomaterials.2011.10.06122079003
   PubMed Web of Science ®Google Scholar
• Ho KS, Aman AM, Al-awar RS, Shoichet MS. Amphiphilic micelles of poly(2-methyl-2-carboxytrimethylene carbonate-co-D,L-lactide)-graft-poly(ethylene glycol) for anti-cancer drug delivery to solid tumours. Biomaterials. 2012;33(7):2223–2229. doi:10.1016/j.biomaterials.2011.11.07222182751
   PubMedGoogle Scholar
• Khurana RK, Beg S, Burrow AJ, et al. Enhancing biopharmaceutical performance of an anticancer drug by long chain PUFA based self-nanoemulsifying lipidic nanomicellar systems. Eur J Pharm Biopharm. 2017;121:42–60. doi:10.1016/j.ejpb.2017.09.00128887099
   PubMed Web of Science ®Google Scholar
• Yu Y, Tan S, Zhao S, et al. Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique. Int J Nanomedicine. 2013;8:2641–2652. doi:10.2147/IJN.S4821423935362
   PubMed Web of Science ®Google Scholar
• Senthilkumar M, Mishra P, Jain NK. Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors. J Drug Target. 2008;16(5):424–435. doi:10.1080/1061186080208859818569287
   PubMed Web of Science ®Google Scholar
• Chao Y, Liang Y, Fang G, et al. Biodegradable polymersomes as nanocarriers for doxorubicin hydrochloride: enhanced cytotoxicity in MCF-7/ADR cells and prolonged blood circulation. Pharm Res. 2017;34(3):610–618. doi:10.1007/s11095-016-2088-928004317
   PubMedGoogle Scholar
• Guo Y, Chu M, Tan S, et al. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance. Mol Pharm. 2014;11(1):59–70. doi:10.1021/mp400514t24229050
   PubMedGoogle Scholar
• Kalaria DR, Sharma G, Beniwal V, Ravi Kumar MN. Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats. Pharm Res. 2009;26(3):492–501. doi:10.1007/s11095-008-9763-418998202
   PubMed Web of Science ®Google Scholar
• Jain A, Agarwal A, Majumder S, et al. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. J Control Release. 2010;148(3):359–367. doi:10.1016/j.jconrel.2010.09.00320854859
   PubMed Web of Science ®Google Scholar
• Zhang W, Sun J, Liu Y, et al. PEG-stabilized bilayer nanodisks as carriers for doxorubicin delivery. Mol Pharm. 2014;11(10):3279–3290. doi:10.1021/mp400566a24754897
   PubMedGoogle Scholar
• Lee JY, Park JH, Lee JJ, et al. Polyethylene glycol-conjugated chondroitin sulfate A derivative nanoparticles for tumor-targeted delivery of anticancer drugs. Carbohydr Polym. 2016;151:68–77. doi:10.1016/j.carbpol.2016.05.04327474544
   PubMed Web of Science ®Google Scholar
• Yu JM, Li YJ, Qiu LY, Jin Y. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization. J Pharm Pharmacol. 2009;61(6):713–719. doi:10.1211/jpp.61.06.000319505361
   PubMed Web of Science ®Google Scholar
• Agarwal A, Gupta U, Asthana A, Jain NK. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent. Biomaterials. 2009;30(21):3588–3596. doi:10.1016/j.biomaterials.2009.03.01619344947
   PubMedGoogle Scholar
• Ahmad N, Ahmad R, Alam MA, et al. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles. Int J Biol Macromol. 2019;128:825–838. doi:10.1016/j.ijbiomac.2019.01.14230690115
   PubMed Web of Science ®Google Scholar
• Varghese SE, Fariya MK, Rajawat GS, Steiniger F, Fahr A, Nagarsenker MS. Lecithin and PLGA-based self-assembled nanocomposite, Lecithmer: preparation, characterization, and pharmacokinetic/pharmacodynamic evaluation. Drug Deliv Transl Res. 2016;6(4):342–353. doi:10.1007/s13346-016-0314-y27371394
   PubMed Web of Science ®Google Scholar
• Li S, Wang A, Jiang W, Guan Z. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles. BMC Cancer. 2008;8:103. doi:10.1186/1471-2407-8-17218412945
   PubMed Web of Science ®Google Scholar
• Kim YH, Lee SJ, Lee SH, Hahn M. Preclinical efficacy and safety assessment of nano-oxaliplatin oral formulation prepared by novel Fat Employing Supercritical Nano System, the FESNS(R). Pharm Dev Technol. 2012;17(6):677–686. doi:10.3109/10837450.2011.56534923216046
   PubMed Web of Science ®Google Scholar
• Kumar R, Kumar P, Singh B, et al. In vivo pharmacokinetic studies and intracellular delivery of methotrexate by means of glycine-tethered PLGA-based polymeric micelles. Int J Pharm. 2017;519(1–2):138–144. doi:10.1016/j.ijpharm.2017.01.02128093326
   PubMedGoogle Scholar
• Zhang H, Wu F, Li Y, et al. Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone. Beilstein J Nanotechnol. 2016;7:1861–1870. doi:10.3762/bjnano.7.17828144535
   PubMed Web of Science ®Google Scholar
• Khare V, Singh A, Mahajan G, et al. Long-circulatory nanoparticles for gemcitabine delivery: development and investigation of pharmacokinetics and in-vivo anticancer efficacy. Eur J Pharm Sci. 2016;92:183–193. doi:10.1016/j.ejps.2016.07.00727404580
   PubMedGoogle Scholar
• Shavi GV, Nayak UY, Maliyakkal N, et al. Nanomedicine of anastrozole for breast cancer: physicochemical evaluation, in vitro cytotoxicity on BT-549 and MCF-7 cell lines and preclinical study on rat model. Life Sci. 2015;141:143–155. doi:10.1016/j.lfs.2015.09.02126423561
   PubMedGoogle Scholar
• Andey T, Sudhakar G, Marepally S, Patel A, Banerjee R, Singh M. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation. Mol Pharm. 2015;12(4):1105–1120. doi:10.1021/mp500862925661724
   PubMedGoogle Scholar
• Shalaby KS, Soliman ME, Bonacucina G, et al. Nanoparticles based on linear and star-shaped poly(ethylene glycol)-poly(epsilon-caprolactone) copolymers for the delivery of antitubulin drug. Pharm Res. 2016;33(8):2010–2024. doi:10.1007/s11095-016-1939-827177721
   PubMedGoogle Scholar
• Woo HN, Chung HK, Ju EJ, et al. Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy. Int J Nanomedicine. 2012;7:2197–2208. doi:10.2147/IJN.S2948022619555
   PubMed Web of Science ®Google Scholar
• Sharma AK, Gupta L, Sahu H, et al. Chitosan engineered PAMAM dendrimers as nanoconstructs for the enhanced anti-cancer potential and improved in vivo brain pharmacokinetics of temozolomide. Pharm Res. 2018;35(1):9. doi:10.1007/s11095-017-2324-y29294212
   PubMed Web of Science ®Google Scholar
• Shukla M, Jaiswal S, Sharma A, et al. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin. Drug Dev Ind Pharm. 2017;43(5):847–861. doi:10.1080/03639045.2016.123973227648633
   PubMed Web of Science ®Google Scholar
• Chaurasia S, Chaubey P, Patel RR, Kumar N, Mishra B. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies. Drug Dev Ind Pharm. 2016;42(5):694–700. doi:10.3109/03639045.2015.106494126165247
   PubMed Web of Science ®Google Scholar
• Lollo G, Ullio-Gamboa G, Fuentes E, Matha K, Lautram N, Benoit JP. In vitro anti-cancer activity and pharmacokinetic evaluation of curcumin-loaded lipid nanocapsules. Mater Sci Eng C Mater Biol Appl. 2018;91:859–867. doi:10.1016/j.msec.2018.06.01430033321
   PubMed Web of Science ®Google Scholar
• Ramaswamy S, Dwarampudi LP, Kadiyala M, et al. Formulation and characterization of chitosan encapsulated phytoconstituents of curcumin and rutin nanoparticles. Int J Biol Macromol. 2017;104:1807–1812. doi:10.1016/j.ijbiomac.2017.06.11228668610
   PubMed Web of Science ®Google Scholar
• Song Z, Zhu W, Song J, et al. Linear-dendrimer type methoxy-poly (ethylene glycol)-b-poly (epsilon-caprolactone) copolymer micelles for the delivery of curcumin. Drug Deliv. 2015;22(1):58–68. doi:10.3109/10717544.2014.90143624725028
   PubMed Web of Science ®Google Scholar
• Yoon IS, Park JH, Kang HJ, et al. Poly(D,L-lactic acid)-glycerol-based nanoparticles for curcumin delivery. Int J Pharm. 2015;488(1–2):70–77. doi:10.1016/j.ijpharm.2015.04.04625900098
   PubMedGoogle Scholar
• Yang X, Liu Y, Zhao Y, et al. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation. Int J Nanomedicine. 2016;11:2979–2994. doi:10.2147/IJN.S10272627382284
   PubMedGoogle Scholar
• Wang A, Li S. Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect. BMC Biotechnol. 2008;8:46. doi:10.1186/1472-6750-8-4618454874
   PubMed Web of Science ®Google Scholar
• Padhi S, Kapoor R, Verma D, Panda AK, Iqbal Z. Formulation and optimization of topotecan nanoparticles: in vitro characterization, cytotoxicity, cellular uptake and pharmacokinetic outcomes. J Photochem Photobiol B. 2018;183:222–232. doi:10.1016/j.jphotobiol.2018.04.02229729631
   PubMed Web of Science ®Google Scholar
• Du Y, Ling L, Ismail M, et al. Redox sensitive lipid-camptothecin conjugate encapsulated solid lipid nanoparticles for oral delivery. Int J Pharm. 2018;549(1–2):352–362. doi:10.1016/j.ijpharm.2018.08.01030099214
   PubMedGoogle Scholar
• Hao L, Wang X, Zhang D, et al. Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals. Int J Pharm. 2012;433(1–2):157–164. doi:10.1016/j.ijpharm.2012.05.00222579996
   PubMedGoogle Scholar
• Jin X, Zhang ZH, Sun E, et al. Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies. Int J Nanomedicine. 2013;8:641–652. doi:10.2147/IJN.S3820323426652
   PubMed Web of Science ®Google Scholar
• Wang L, Luo Q, Lin T, et al. PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A. Drug Dev Ind Pharm. 2015;41(7):1204–1212. doi:10.3109/03639045.2014.93808225010850
   PubMed Web of Science ®Google Scholar
• Freag MS, Saleh WM, Abdallah OY. Self-assembled phospholipid-based phytosomal nanocarriers as promising platforms for improving oral bioavailability of the anticancer celastrol. Int J Pharm. 2018;535(1–2):18–26. doi:10.1016/j.ijpharm.2017.10.05329102699
   PubMed Web of Science ®Google Scholar
• Liu TT, Mu LQ, Dai W, Wang CB, Liu XY, Xiang DX. Preparation, characterization, and evaluation of antitumor effect of Brucea javanica oil cationic nanoemulsions. Int J Nanomedicine. 2016;11:2515–2529. doi:10.2147/IJN.S10191827330293
   PubMed Web of Science ®Google Scholar
• Zhang T, Wang H, Ye Y, Zhang X, Wu B. Micellar emulsions composed of mPEG-PCL/MCT as novel nanocarriers for systemic delivery of genistein: a comparative study with micelles. Int J Nanomedicine. 2015;10:6175–6184. doi:10.2147/IJN.S9134826491290
   PubMed Web of Science ®Google Scholar
• Gao Y, Qi X, Zheng Y, et al. Nanoemulsion enhances alpha-tocopherol succinate bioavailability in rats. Int J Pharm. 2016;515(1–2):506–514. doi:10.1016/j.ijpharm.2016.10.02627746330
   PubMedGoogle Scholar